Children's Hospital Los Angeles is a nationally ranked, freestanding acute care children's hospital in the East Hollywood district of Los Angeles, on Sunset Boulevard at the corner of Vermont Avenue.

There are 495 beds in Children's Hospital Los Angeles.

During the past decade, Children's Hospital Los Angeles conducted 496 clinical trials. In the 10-year time frame, 496 clinical trials started and 286 clinical trials were completed, i.e. on average, 57.7% percent of trials that started reached the finish line to date. In the past 5 years, 197 clinical trials started and 155 clinical trials were completed. i.e. 78.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Hospital Los Angeles" #1 sponsor was "Children's Oncology Group" with 175 trials, followed by "Children's Hospital Los Angeles" with 97 trials sponsored, "National Cancer Institute (NCI)" with 90 trials sponsored, "University of North Carolina, Chapel Hill" with 42 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 42 trials sponsored. Other sponsors include 556 different institutions and companies that sponsored additional 242 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Hospital Los Angeles" #1 collaborator was "National Cancer Institute (NCI)" with 226 trials as a collaborator, "Children's Hospital Los Angeles" with 56 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 39 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 37 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 34 trials as a collaborator. Other collaborators include 920 different institutions and companies that were collaborators in the rest 425 trials.

According to Clinical.Site data, the most researched conditions in "Children's Hospital Los Angeles" are "Neuroblastoma" (53 trials), "Leukemia" (39 trials), "HIV Infections" (34 trials), "Cystic Fibrosis" (32 trials) and "Recurrent Neuroblastoma" (30 trials). Many other conditions were trialed in "Children's Hospital Los Angeles" in a lesser frequency.

Most popular intervention types in "Children's Hospital Los Angeles" are "Drug" (614 trials), "Other" (218 trials), "Biological" (181 trials), "Procedure" (138 trials) and "Radiation" (105 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (81 trials), "Cyclophosphamide" (62 trials), "Placebo" (61 trials), "cyclophosphamide" (47 trials) and "Pharmacological Study" (43 trials). Other intervention names were less common.

The vast majority of trials in "Children's Hospital Los Angeles" are 933 trials for "All" genders, 34 trials for "Male" genders and 16 trials for "Female" genders.

Currently, there are 375 active trials in "Children's Hospital Los Angeles". 7 are not yet recruiting, 181 are recruiting, 172 are Active, not recruiting, and 15 are Enrolling by invitation. In total, there were 495 completed trials in Children's Hospital Los Angeles, 6 suspended trials, and 63 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Hospital Los Angeles, 180 "Phase 1" clinical trials were conducted, 301 "Phase 2" clinical trials and 241 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 29 trials, and there were also 126 trials that are defined as “Not Applicable".

Children's Hospital Los Angeles has several departments that took part in Clinical trials: "Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy" - 8 trials, "Children´s Hospital Los Angeles, Hemophilia Comprehensive Care Center, Division of Pediatric Hematology/Oncology" - 2 trials, "Children's Hospital of Los Angeles (Data Collection Only)" - 2 trials, "Children's Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles" - 2 trials